Skip to main
STAA

STAAR Surgical (STAA) Stock Forecast & Price Target

STAAR Surgical (STAA) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 29%
Buy 0%
Hold 71%
Sell 0%
Strong Sell 0%

Bulls say

Staar Surgical is positioned for growth due to multiple factors: a strong recovery in China, successful execution of their restructuring plans to improve costs and efficiencies, and a favorable market for their product (phakic IOLs) with potential for expansion into new indications. Additionally, the company has potential for growth through its successful expansion into the Chinese market, as well as opportunities with the emergence of new technologies like SMILE, which could be complementary to STAAR's offerings. While there are risks, such as intensifying competition and manufacturing constraints, STAAR has a strong track record and we believe its innovative products and revenue-generating business model will continue to drive value for the company.

Bears say

Staar Surgical is facing potential risks and uncertainties due to its financials, leadership changes, and competition in China, despite its unique market position and focus on implantable lenses. The company's reliance on foreign sales poses a risk, particularly in light of its recent difficulties in China and potential threats from competitors. Additionally, the involvement of activist shareholders and the merger with Alcon could add further challenges for the company's growth and success in the coming years.

STAAR Surgical (STAA) has been analyzed by 7 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 0% recommend Buy, 71% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of STAAR Surgical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About STAAR Surgical (STAA) Forecast

Analysts have given STAAR Surgical (STAA) a Buy based on their latest research and market trends.

According to 7 analysts, STAAR Surgical (STAA) has a Buy consensus rating as of May 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $22.07, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $22.07, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

STAAR Surgical (STAA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.